Home » Topics » BioWorld Science

BioWorld Science
RSS

Antigen transfer can induce CAR T friendly fire

April 5, 2019

Preclinical results for anti-HER2 TLR8 agonist conjugate for the treatment of HER2-expressing tumors

April 5, 2019

Patient recruitment ongoing in phase I study of TPST-1120

April 5, 2019

FDA clears IND application for phase I/II study of HMI-102 gene therapy candidate

April 5, 2019

First subject dosed in phase I study of SM-07883

April 5, 2019

Entasis Therapeutics initiates global phase III ATTACK study of ETX-2514SUL

April 5, 2019

Amgen identifies KRAS mutant inhibitors

April 5, 2019

Fate Therapeutics gives update on phase I study of FT-500

April 5, 2019

Phase I results of highly selective dual IDO1/TDO2 inhibitor M-4112 in advanced solid malignancies

April 4, 2019

Comparison of the novel biguanide NT-1195 with metformin/phenformin in endometrial cancer models

April 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...